Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy is a research paper published in Journal of Clinical Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: UM1 HL087318
the University of Florida Regional Clinical Center CCTRN Training Core Supplement
Grant: UM1 HL087366
NHLBI: Brain-Gut Microbiome-Immune Axis in Hypertension
Grant: HL132448
The Gatorade Trust
Grant: 00128251
The Gatorade Trust:
Grant: 00128225
National Institutes of Health, National Center for Advancing Translational Sciences–University of Florida Clinical and Translational Science
Grant: UL1TR001427
PCORnet – One Florida Clinical Research Consortium, Clinical Data Research Network–1501
Grant: 26692
The Romanian-American Fulbright Commission
Grant: N/A
National Institutes of Health
Grant: 4UM1HL087318-10
Data Coordinating Center For The Cardiovascular Cell Therapy Research Network
National Institutes of Health
Grant: 5UL1TR001427-08
Together: Transforming and Translating Discovery to Improve Health
National Institutes of Health
Grant: 5UL1TR001427-04
Together: Transforming and Translating Discovery to Improve Health
National Institutes of Health
Grant: 5UM1HL087366-08
UFRCC for Cardiovascular Cell Therapy Research Network
FWCI
1.12
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals